Gladius Capital Management’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,752
Closed -$17.7K 231
2023
Q3
$17.7K Buy
+19,752
New +$17.7K ﹤0.01% 251